0001225208-17-002829.txt : 20170210
0001225208-17-002829.hdr.sgml : 20170210
20170210182305
ACCESSION NUMBER: 0001225208-17-002829
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170208
FILED AS OF DATE: 20170210
DATE AS OF CHANGE: 20170210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEILAND JOHN H
CENTRAL INDEX KEY: 0001204663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 17595081
MAIL ADDRESS:
STREET 1: C/O C.R BARD INC
STREET 2: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2017-02-08
0000009892
BARD C R INC /NJ/
BCR
0001204663
WEILAND JOHN H
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
1
Vice Chairman, Pres. and COO
Common Stock
2017-02-08
4
A
0
22023.0000
0.0000
A
83613.2900
D
Common Stock
2017-02-08
4
A
0
6788.0000
0.0000
A
90401.2900
D
Common Stock
2017-02-08
4
A
0
4303.0000
235.4900
A
94704.2900
D
Common Stock
2017-02-08
4
A
0
1844.0000
164.8430
A
96548.2900
D
Common Stock
2017-02-08
4
F
0
11136.0000
236.6800
D
85412.2900
D
Common Stock
2017-02-09
4
S
0
200.0000
239.9800
D
85212.2900
D
Common Stock
2017-02-09
4
S
0
14081.0000
239.5381
D
71131.2900
D
Common Stock
5967.0470
I
401(k) Plan
Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019.
Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $238.90 to $239.83. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 24.786 shares acquired under the Company's 401(k) Plan from November 5, 2016 to February 3, 2017.
Myra McGinley, Attorney-in-Fact
2017-02-10